Λίστα αντικειμένων
Blood 2015; 126: 415-422
This paper demonstrates that in CB tranplantation for highhj risk AML the addtion of HD ARA-C before TBI/CY myeloabaltive conditioning reduces risk of relapse without added effect on TRM.
Blood 2015; 126: 415-422
This paper demonstrates that in CB tranplantation for highhj risk AML the addtion of HD ARA-C before TBI/CY myeloabaltive conditioning reduces risk of relapse without added effect on TRM.
Τηλέφωνα Επικοινωνίας: